BamSEC and AlphaSense Join Forces
Learn More

Keros Therapeutics Inc. – Indentures

NASDAQ: KROS    
Share price (8/12/26): $11.20    
Market cap (8/12/26): $222 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.4
from 10-K 5 pages Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 8-K 55 pages Rights Agreement April 9, 2025
12/34/56
EX-4.3
from 10-K 3 pages Description of Keros Therapeutics, Inc. Common Stock
12/34/56
EX-4.9
from S-3ASR 19 pages Keros Therapeutics, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Keros Therapeutics, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.8
from S-3ASR 21 pages Keros Therapeutics, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Keros Therapeutics, Inc. Form of Preferred Stock Warrant Agreement
12/34/56
EX-4.7
from S-3ASR 20 pages Keros Therapeutics, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of Keros Therapeutics, Inc. Form of Common Stock Warrant Agreement
12/34/56
EX-4.4
from S-3ASR 49 pages Keros Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [L], 20__ Debt Securities
12/34/56
EX-4.3
from 10-K 3 pages Description of Keros Therapeutics, Inc. Common Stock
12/34/56
EX-4.3
from 10-K 3 pages Description of Keros Therapeutics, Inc. Common Stock
12/34/56
EX-4.3
from 10-K 3 pages Description of Keros Therapeutics, Inc. Common Stock
12/34/56
EX-4.9
from S-3ASR 18 pages Keros Therapeutics, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Keros Therapeutics, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.8
from S-3ASR 20 pages Keros Therapeutics, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Keros Therapeutics, Inc. Form of Preferred Stock Warrant Agreement
12/34/56
EX-4.7
from S-3ASR 20 pages Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.4
from S-3ASR 47 pages Keros Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [•], 20__ Debt Securities
12/34/56
EX-4.3
from 10-K 3 pages Description of Keros Therapeutics, Inc. Common Stock
12/34/56
EX-4.2
from S-1/A 2 pages Indenture or similar
12/34/56
EX-4.1
from S-1 44 pages Amended and Restated Investors’ Rights Agreement
12/34/56
EX-4.1
from DRS 31 pages Amended and Restated Investors’ Rights Agreement
12/34/56